{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:37:30Z","timestamp":1783633050500,"version":"3.55.0"},"reference-count":57,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.2967\/jnumed.117.204834","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T17:55:45Z","timestamp":1532454945000},"page":"1566-1573","source":"Crossref","is-referenced-by-count":23,"title":["Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine"],"prefix":"10.2967","volume":"59","author":[{"given":"Caroline","family":"Martini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Buxbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Nilica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Holzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Gamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"2021051712123115000_59.10.1566.1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29099"},{"key":"2021051712123115000_59.10.1566.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"2021051712123115000_59.10.1566.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300831"},{"key":"2021051712123115000_59.10.1566.4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ecc.12085","article-title":"Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review","volume":"22","author":"Chau","year":"2013","journal-title":"Eur J Cancer Care (Engl)."},{"key":"2021051712123115000_59.10.1566.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1477-2574.2010.00175.x"},{"key":"2021051712123115000_59.10.1566.6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105"},{"key":"2021051712123115000_59.10.1566.7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.038"},{"key":"2021051712123115000_59.10.1566.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2330-6"},{"key":"2021051712123115000_59.10.1566.9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12955-016-0527-2","article-title":"Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours","volume":"14","author":"Martini","year":"2016","journal-title":"Health Qual Life Outcomes."},{"key":"2021051712123115000_59.10.1566.10","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1007\/s00520-016-3189-z","article-title":"Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden","volume":"24","author":"Pearman","year":"2016","journal-title":"Support Care Cancer."},{"key":"2021051712123115000_59.10.1566.11","doi-asserted-by":"publisher","DOI":"10.1097\/00002820-199812000-00005"},{"key":"2021051712123115000_59.10.1566.12","doi-asserted-by":"publisher","DOI":"10.1080\/028418699432022"},{"key":"2021051712123115000_59.10.1566.13","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008360718646"},{"key":"2021051712123115000_59.10.1566.14","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-18"},{"key":"2021051712123115000_59.10.1566.15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1365-2354.2003.00322.x","article-title":"Distress, quality of life and strategies to \u2018keep a good mood\u2019 in patients with carcinoid tumours: patient and staff perceptions","volume":"12","author":"Larsson","year":"2003","journal-title":"Eur J Cancer Care (Engl)."},{"key":"2021051712123115000_59.10.1566.16","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9487-x"},{"key":"2021051712123115000_59.10.1566.17","doi-asserted-by":"publisher","DOI":"10.1080\/02841860152703445"},{"key":"2021051712123115000_59.10.1566.18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2016.01.009","article-title":"Effectiveness and side-effects of peptide receptor radionuclide therapy for neuroendocrine neoplasms in Germany: a multi-institutional registry study with prospective follow-up","volume":"58","author":"H\u00f6rsch","year":"2016","journal-title":"Eur J Cancer."},{"key":"2021051712123115000_59.10.1566.19","first-page":"420PD","article-title":"NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: efficacy, safety, QoL results and subgroup analysis","volume":"27","author":"Strosberg","year":"2016","journal-title":"Ann Oncol."},{"key":"2021051712123115000_59.10.1566.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.087932"},{"key":"2021051712123115000_59.10.1566.21","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0078"},{"key":"2021051712123115000_59.10.1566.22","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.105"},{"key":"2021051712123115000_59.10.1566.23","first-page":"62S","article-title":"Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs","volume":"46","author":"Kwekkeboom","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712123115000_59.10.1566.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.07.030"},{"key":"2021051712123115000_59.10.1566.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.016"},{"key":"2021051712123115000_59.10.1566.26","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp372"},{"key":"2021051712123115000_59.10.1566.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1902-1"},{"key":"2021051712123115000_59.10.1566.28","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000113"},{"key":"2021051712123115000_59.10.1566.29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00259-017-3816-z","article-title":"Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30","volume":"45","author":"Marinova","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712123115000_59.10.1566.30","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-211"},{"key":"2021051712123115000_59.10.1566.31","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv181"},{"key":"2021051712123115000_59.10.1566.32","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-0054-x"},{"key":"2021051712123115000_59.10.1566.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.078"},{"key":"2021051712123115000_59.10.1566.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.4553"},{"key":"2021051712123115000_59.10.1566.35","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00259-015-3022-9","article-title":"Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme","volume":"42","author":"Gamper","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712123115000_59.10.1566.36","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310023453"},{"key":"2021051712123115000_59.10.1566.37","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2021051712123115000_59.10.1566.38","unstructured":"Fayers PM Aaronson NK Bjordal K Groenvold M Curran D Bottomley A . The EORTC QLQ-C30 Scoring Manual. 3rd ed. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 2001."},{"key":"2021051712123115000_59.10.1566.39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol."},{"key":"2021051712123115000_59.10.1566.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.01.004"},{"key":"2021051712123115000_59.10.1566.41","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2014.1741"},{"key":"2021051712123115000_59.10.1566.42","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0488"},{"key":"2021051712123115000_59.10.1566.43","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clinthera.2016.03.002","article-title":"Patient-reported symptom experiences in patients with carcinoid syndrome after participation in a study of telotristat etiprate: a qualitative interview approach","volume":"38","author":"Gelhorn","year":"2016","journal-title":"Clin Ther."},{"key":"2021051712123115000_59.10.1566.44","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3182328045"},{"key":"2021051712123115000_59.10.1566.45","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/57.3.S168"},{"key":"2021051712123115000_59.10.1566.46","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.3.480"},{"key":"2021051712123115000_59.10.1566.47","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199803000-00006"},{"key":"2021051712123115000_59.10.1566.48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1756283X16674660","article-title":"Everolimus in the management of metastatic neuroendocrine tumours","volume":"10","author":"Chan","year":"2017","journal-title":"Therap Adv Gastroenterol."},{"key":"2021051712123115000_59.10.1566.49","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1470-2045(17)30471-0","article-title":"Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"18","author":"Pavel","year":"2017","journal-title":"Lancet Oncol."},{"key":"2021051712123115000_59.10.1566.50","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-016-0440-y"},{"key":"2021051712123115000_59.10.1566.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003825"},{"key":"2021051712123115000_59.10.1566.52","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.560"},{"key":"2021051712123115000_59.10.1566.53","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e31819b6441"},{"key":"2021051712123115000_59.10.1566.54","unstructured":"Devlin NJ Appleby J . Getting the Most out of PROMS: Putting Health Outcomes at the Heart of NHS Decision-Making. London, U.K.: The King\u2019s Fund; 2010."},{"key":"2021051712123115000_59.10.1566.55","unstructured":"Aaronson N Elliott T Greenhalgh J . User\u2019s Guide to Implementing Patient-Reported Outcomes Assessment in Clinical Practice. Milwaukee, WI: International Society for Quality of Life Research; 2015."},{"key":"2021051712123115000_59.10.1566.56","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.001423"},{"key":"2021051712123115000_59.10.1566.57","doi-asserted-by":"crossref","unstructured":"Cella D Hahn EA Jensen SE . Patient-Reported Outcomes in Performance Measurement. Research Triangle Park, NC: RTI Press; 2015.","DOI":"10.3768\/rtipress.2015.bk.0014.1509"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.204834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:29:23Z","timestamp":1621283363000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.204834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10,1]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.2967\/jnumed.117.204834"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.204834","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]}}}